More recently, it has been demonstrated that the expression of the GCS gene in drug-resistant K562/AO2 human leukemia cells was higher than that in drug-sensitive K562 cells, and the sensitivity of K562/AO2 cells to adriamycin was enhanced by GCS inhibition [6]. The gene discussed is UGCG; the disease is leukemia.